Nucleoside reverse transcriptase inhibitors (NRTIs)

APO AB 300 Pill - yellow capsule-shape, 15mm

Pill with imprint APO AB 300 is Yellow, Capsule-shape and has been identified as Abacavir Sulfate 300 mg (base). It is supplied by Apotex Corp.

Abacavir is used in the treatment of HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Abacavir 300 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images

Abacavir (Abacavir [ a-bak-a-veer ])-APO AB 300-300 mg (base)-Yellow-Capsule-shape
Abacavir (Abacavir [ a-bak-a-veer ])-APO AB 300-300 mg (base)-Yellow-Capsule-shape

Abacavir
Generic Name: abacavir [ a-bak-a-veer ]
Imprint: APO AB 300
Strength: 300 mg (base)
Color: Yellow
Size: 15.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Silicon dioxide, Magnesium stearate, Microcrystalline cellulose, Hypromelloses, Polyethylene glycol 8000, Ferric oxide yellow, Croscarmellose sodium, Titanium dioxide,
Latest News
Related Drugs